Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension
Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Ghazwan Butrous(University of Kent), Eva Berghausen(University of Cologne), Stephan Rosenkranz(University of Cologne), Elsa Butrous(Goethe University Frankfurt), Norbert Weißmann(Cardio-Pulmonary Institute), Rajkumar Savai(Goethe University Frankfurt), Ralf P. Brandes(Goethe University Frankfurt), Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Aleksandra Tretyn(Max Planck Institute for Heart and Lung Research), Swati Dabral(University of Würzburg), Bhola K. Dahal, Werner Seeger(Justus-Liebig-Universität Gießen)
Cited by 124
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k